Kore Potash PLC
LSE:KP2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kore Potash PLC
LSE:KP2
|
UK |
|
T
|
Trendzon Holdings Group Ltd
HKEX:1865
|
SG |
|
F
|
Foundpac Group Bhd
KLSE:FPGROUP
|
MY |
|
Iqstel Inc
OTC:IQST
|
US |
|
SKF India Ltd
NSE:SKFINDIA
|
IN |
|
J
|
Johnson Pharmacare Ltd
BSE:532154
|
IN |
|
Glory Flame Holdings Ltd
HKEX:8059
|
HK |
|
S
|
Solteq Oyj
OMXH:SOLTEQ
|
FI |
|
AK Medical Holdings Ltd
HKEX:1789
|
CN |
Balance Sheet
Balance Sheet Decomposition
Kore Potash PLC
Kore Potash PLC
Balance Sheet
Kore Potash PLC
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
43
|
20
|
5
|
6
|
3
|
43
|
16
|
6
|
8
|
6
|
11
|
5
|
2
|
1
|
11
|
|
| Cash |
43
|
20
|
5
|
6
|
0
|
43
|
16
|
6
|
8
|
6
|
11
|
5
|
2
|
1
|
11
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
44
|
21
|
3
|
6
|
3
|
43
|
17
|
7
|
8
|
6
|
11
|
5
|
2
|
2
|
11
|
|
| PP&E Net |
55
|
89
|
93
|
110
|
94
|
96
|
141
|
150
|
157
|
173
|
167
|
163
|
177
|
170
|
199
|
|
| PP&E Gross |
55
|
89
|
93
|
110
|
0
|
0
|
141
|
150
|
157
|
173
|
167
|
163
|
177
|
170
|
199
|
|
| Accumulated Depreciation |
0
|
1
|
0
|
1
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
99
N/A
|
109
+11%
|
97
-11%
|
116
+20%
|
97
-17%
|
139
+44%
|
158
+13%
|
157
0%
|
165
+5%
|
178
+8%
|
178
+0%
|
168
-6%
|
179
+6%
|
171
-4%
|
210
+23%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
5
|
5
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
2
|
0
|
1
|
1
|
0
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
3
|
0
|
|
| Total Current Liabilities |
6
|
5
|
0
|
0
|
0
|
0
|
3
|
2
|
3
|
1
|
1
|
1
|
1
|
4
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Liabilities |
6
N/A
|
5
-22%
|
0
-93%
|
0
+25%
|
0
-25%
|
0
-33%
|
3
+1 523%
|
2
-50%
|
2
+50%
|
0
-91%
|
1
+129%
|
0
-64%
|
3
+1 440%
|
3
+17%
|
0
N/A
|
|
| Equity | ||||||||||||||||
| Common Stock |
123
|
138
|
155
|
151
|
155
|
201
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
4
|
5
|
|
| Retained Earnings |
32
|
32
|
58
|
38
|
58
|
62
|
162
|
157
|
154
|
151
|
149
|
148
|
147
|
146
|
145
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
32
|
44
|
45
|
47
|
50
|
71
|
|
| Other Equity |
1
|
1
|
0
|
2
|
0
|
0
|
9
|
2
|
7
|
7
|
19
|
27
|
22
|
32
|
11
|
|
| Total Equity |
93
N/A
|
105
+13%
|
96
-8%
|
116
+20%
|
96
-17%
|
139
+44%
|
154
+11%
|
155
+1%
|
162
+5%
|
178
+10%
|
178
0%
|
168
-5%
|
176
+4%
|
168
-4%
|
210
+25%
|
|
| Total Liabilities & Equity |
99
N/A
|
109
+11%
|
97
-11%
|
116
+20%
|
97
-17%
|
139
+44%
|
158
+13%
|
157
0%
|
165
+5%
|
178
+8%
|
178
+0%
|
168
-6%
|
179
+6%
|
171
-4%
|
210
+23%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
230
|
290
|
410
|
382
|
410
|
729
|
771
|
861
|
1 541
|
2 452
|
3 375
|
3 420
|
4 120
|
4 378
|
5 176
|
|